These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 35400336)
1. Identification of Immune Infiltration and Prognostic Biomarkers in Small Cell Lung Cancer Based on Bioinformatic Methods from 3 Studies. Cao J; Yu C Comb Chem High Throughput Screen; 2023; 26(3):507-516. PubMed ID: 35400336 [TBL] [Abstract][Full Text] [Related]
2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related]
3. Identification of Six Novel Prognostic Gene Signatures as Potential Biomarkers in Small Cell Lung Cancer. Feng S; Zhang X; Gu X; Zhou M; Chen Y; Wang C Comb Chem High Throughput Screen; 2023; 26(5):938-949. PubMed ID: 35490316 [TBL] [Abstract][Full Text] [Related]
4. Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis. Dong S; Liang J; Zhai W; Yu Z Mol Genet Genomic Med; 2020 Mar; 8(3):e1126. PubMed ID: 31981472 [TBL] [Abstract][Full Text] [Related]
5. Identification of Key Biomarkers and Pathways in Small-Cell Lung Cancer Using Biological Analysis. Liu H; Li T; Ye X; Lyu J Biomed Res Int; 2021; 2021():5953386. PubMed ID: 34712733 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis. Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076 [TBL] [Abstract][Full Text] [Related]
7. Prognostic biomarkers and immune cell infiltration characteristics in small cell lung cancer. Ni J; Si X; Wang H; Zhang X; Zhang L Cancer Pathog Ther; 2023 Jan; 1(1):18-24. PubMed ID: 38328611 [TBL] [Abstract][Full Text] [Related]
8. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer. Wu Z; Wang YM; Dai Y; Chen LA Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer. Song Y; Sun Y; Sun T; Tang R Comb Chem High Throughput Screen; 2020; 23(5):381-391. PubMed ID: 32264809 [TBL] [Abstract][Full Text] [Related]
10. Identification of key genes and biological pathways in Chinese lung cancer population using bioinformatics analysis. Liu P; Li H; Liao C; Tang Y; Li M; Wang Z; Wu Q; Zhou Y PeerJ; 2022; 10():e12731. PubMed ID: 35178291 [TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer. Zhou M; Chen Y; Gu X; Wang C Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144 [No Abstract] [Full Text] [Related]
12. Identification of effective diagnostic genes and immune cell infiltration characteristics in small cell lung cancer by integrating bioinformatics analysis and machine learning algorithms. Chen Y; Han K; Liu Y; Wang Q; Wu Y; Chen S; Yu J; Luo Y; Tan L Saudi Med J; 2024 Aug; 45(8):771-782. PubMed ID: 39074893 [TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods. Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409 [TBL] [Abstract][Full Text] [Related]
14. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis. Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846 [No Abstract] [Full Text] [Related]
15. Construction of Prognostic Risk Model for Small Cell Lung Cancer Based on Immune-Related Genes. Deng F; Tao F; Xu Z; Zhou J; Gong X; Zhang R Comput Math Methods Med; 2022; 2022():7116080. PubMed ID: 36245844 [TBL] [Abstract][Full Text] [Related]
16. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer. Liu X; Liu X; Li J; Ren F Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030 [TBL] [Abstract][Full Text] [Related]
17. Network analysis of differentially expressed genes reveals key genes in small cell lung cancer. Tantai JC; Pan XF; Zhao H Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1364-72. PubMed ID: 25967710 [TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
19. Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis. Wang H; Lu L; Liang X; Chen Y Cancer Immunol Immunother; 2022 Jul; 71(7):1757-1769. PubMed ID: 34854950 [TBL] [Abstract][Full Text] [Related]
20. The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation. Yin Y; Li D; He M; Wang J Transl Cancer Res; 2022 Aug; 11(8):2622-2635. PubMed ID: 36093542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]